1

article4

05.14.2020

Related Articles

The Pharma Market Access Landscape in the Middle East and North Africa: The Next Ten Years

Introduction The market access landscape in the Middle East and North Africa is changing rapidly. The region is diverse, comprises many dissimilar countries, and different cultures including languages used in commerce. There are also different approaches to regulating healthcare markets, and concerns about the long-term sustainability of oil revenues shape healthcare markets. There are other […]

Read all
Value-Based Pricing of New Technologies

What is value-based pricing? Value-based pricing aims to reward pharmaceutical companies and medical device companies for investments in new healthcare technologies that result in sustained improvements in patient quality of life. We also expect such technologies to deliver measurable net economic benefits for society. In economic theory, value-based pricing is when a buyer’s willingness to […]

Read all
Budget Impact Analysis

What is Budget Impact Analysis? Pharmacoeconomic analyses in healthcare are paramount, because of the high costs of innovative technologies and limited possibilities of their funding. Budget Impact Analysis (BIA) is one such analysis that provides vital information for healthcare decision makers [1].  Unlike economic evaluations, such as cost-effectiveness analysis (CEA), cost-utility analysis (CUA) and cost-benefit […]

Read all
Read all articles